Brii Biosciences Ltd

13D and 13G Filings

13D/G filings
13G on 1 security
CIK
0001965619
All SEC filings
View on sec.gov
Issuer % of Class Filed
Schedule 13G · 1 security · passive
AN2 Therapeutics, Inc. 13G/A
ANTX · 037326105
3.1% 2/14/2025
Event 12/31/2024

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.